Little Rock, Arkansas – A researcher at the University of Arkansas for Medical Sciences (UAMS) has received a major federal grant to investigate the link between diabetes and cardiovascular disease. Assistant Professor Yunmeng Liu, Ph.D., of the Department of Pharmacology and Toxicology, was recently awarded a five-year $3.6 million grant from the National Institutes of Health to support her work.
Officials explained that Liu’s research will focus on how metabolic abnormalities in immune cells during diabetes contribute to high blood pressure and damage to the heart and kidneys. These complications, they said, are common comorbidities in patients with diabetes, making the study highly relevant to public health.
“The goal of our study is to understand why diabetes promotes cardiovascular disease and renal injury,” officials noted. Liu emphasized the importance of investigating the cellular mechanisms behind these conditions, which could eventually lead to more effective treatments for patients.
For Liu, the grant represents a major milestone for her laboratory. “This is a significant milestone for our lab,” she said. She also expressed gratitude to her collaborators at UAMS, crediting their support and expertise as essential to the success of the grant proposal.
The research will take place over the next five years and is expected to provide valuable insights into how diabetes triggers systemic complications, particularly in the cardiovascular and renal systems. By studying immune cells and metabolic dysfunction, Liu hopes to identify potential pathways for therapeutic intervention.
Officials at UAMS said the funding will support not only the research itself but also training opportunities for students and early-career scientists in the lab. This aligns with the institution’s commitment to fostering innovation and advancing medical knowledge in fields that impact millions of Americans.
“This grant will allow us to address critical questions at the intersection of metabolic and cardiovascular health,” Liu said. Her work has the potential to influence how clinicians understand and treat diabetic patients who are at risk for heart and kidney disease.
For more information about the research and updates from Dr. Liu’s laboratory, officials encourage the public to visit UAMS.com. The project highlights the ongoing efforts at UAMS to combine basic scientific research with clinical applications to improve patient outcomes.
With the support of the NIH and the UAMS community, Liu’s research promises to shed new light on the mechanisms linking diabetes to cardiovascular and renal complications, offering hope for future therapies and improved patient care.
